» Articles » PMID: 33800954

Interactions of SARS-CoV-2 with the Blood-Brain Barrier

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 3
PMID 33800954
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging data indicate that neurological complications occur as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The blood-brain barrier (BBB) is a critical interface that regulates entry of circulating molecules into the CNS, and is regulated by signals that arise from the brain and blood compartments. In this review, we discuss mechanisms by which SARS-CoV-2 interactions with the BBB may contribute to neurological dysfunction associated with coronavirus disease of 2019 (COVID-19), which is caused by SARS-CoV-2. We consider aspects of peripheral disease, such as hypoxia and systemic inflammatory response syndrome/cytokine storm, as well as CNS infection and mechanisms of viral entry into the brain. We also discuss the contribution of risk factors for developing severe COVID-19 to BBB dysfunction that could increase viral entry or otherwise damage the brain.

Citing Articles

Late-Onset Idiopathic Generalized Epilepsy Manifesting With De Novo Late-Onset Absence Status Epilepticus After COVID-19 Infection: A Case Report.

Otake M, Taniguchi G, Kato H, Fuji Y, Nakata C, Nakagawa E Cureus. 2024; 16(11):e74618.

PMID: 39735007 PMC: 11681944. DOI: 10.7759/cureus.74618.


Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, L., in Long COVID and Other Conditions Involving Cognitive Impairment.

Papadopoulou P, Polissidis A, Kythreoti G, Sagnou M, Stefanatou A, Theoharides T Int J Mol Sci. 2024; 25(20).

PMID: 39456822 PMC: 11507169. DOI: 10.3390/ijms252011040.


Cerebral small vessel injury in mice with damage to ACE2-expressing cerebral vascular endothelial cells and post COVID-19 patients.

Lu J, Zuo X, Cai A, Xiao F, Xu Z, Wang R Alzheimers Dement. 2024; 20(11):7971-7988.

PMID: 39352003 PMC: 11567838. DOI: 10.1002/alz.14279.


Neurological complications caused by SARS-CoV-2.

Pang Z, Tang A, He Y, Fan J, Yang Q, Tong Y Clin Microbiol Rev. 2024; 37(4):e0013124.

PMID: 39291997 PMC: 11629622. DOI: 10.1128/cmr.00131-24.


Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease.

Navolokin N, Adushkina V, Zlatogorskaya D, Telnova V, Evsiukova A, Vodovozova E Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931455 PMC: 11206883. DOI: 10.3390/ph17060788.


References
1.
Li H, Xiang X, Ren H, Xu L, Zhao L, Chen X . Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis. J Infect. 2020; 80(6):646-655. PMC: 7141628. DOI: 10.1016/j.jinf.2020.03.035. View

2.
Watanabe R, Kakizaki M, Ikehara Y, Togayachi A . Formation of fibroblastic reticular network in the brain after infection with neurovirulent murine coronavirus. Neuropathology. 2016; 36(6):513-526. PMC: 7167860. DOI: 10.1111/neup.12302. View

3.
Cipolla M, Crete R, Vitullo L, Rix R . Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. Front Biosci. 2004; 9:777-85. DOI: 10.2741/1282. View

4.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View

5.
Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L . Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020; 71(15):889-890. PMC: 7184514. DOI: 10.1093/cid/ciaa330. View